Jonathan Andrus

Jonathan Andrus

President chez Crio, Inc.

Commercial Services
Health Services
Technology Services

Profil

Jonathan R.
Andrus
is currently the Chief Business Officer at Clinical Ink, Inc. He is also a Member at the American Society For Quality, Inc., a Trustee at the Society for Clinical Data Management, Inc., and the President & Chief Operating Officer at Crio, Inc. Previously, he served as the Chairman at Drug Information Association from 2012 to 2017.
He was also the Vice President-Data Management & Quality at BioClinica, Inc. from 2011 to 2012.
Additionally, he worked as a Principal at Premier Research Group Ltd.
and as the Vice President-Regulatory Operations at Phoenix Data Systems, Inc. Mr. Andrus completed his undergraduate and graduate degrees at Temple University (Pennsylvania).

Postes actifs de Jonathan Andrus

SociétésPosteDébut
Corporate Officer/Principal -
Society for Clinical Data Management, Inc. Directeur/Membre du Conseil 12/05/2010
Corporate Officer/Principal 15/06/2015
President -
Tous les postes actifs de Jonathan Andrus

Anciens postes connus de Jonathan Andrus

SociétésPosteFin
Président 03/08/2017
BIOCLINICA INC Conseiller Juridique Général 14/05/2010
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Jonathan Andrus

Formation de Jonathan Andrus

Temple University (Pennsylvania) Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Jonathan Andrus

Relations

100 +

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées8

Health Services

Commercial Services

Technology Services

Technology Services

Commercial Services

Commercial Services

Health Services

Society for Clinical Data Management, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Jonathan Andrus
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT